ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942523P0041
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $250,000
- Period of performance
- Jun 30, 2023 – Jan 29, 2024
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN11
- Place of performance
- NC
Public award description
ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.